Volunteers are being injected as part of phase 3 trials of Turkovac, Turkey's nationally developed vaccine candidate against COVID-19, in the country's capital at Ankara City Hospital.
#Ankara
#Volunteers
#Turkovac
The BIST name and logo are protected under the "Protected Trademark Certificate" and cannot be used, quoted, or altered without permission.All rights to the information disclosed under the BIST name are entirely owned by BIST and cannot be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.